Skip to content
value.today

Vernal Biosciences, Inc.

🇺🇸 Stowe, Vermont, USABiotechnologyFounded 2020
Total raised
$43 M
2 rounds on record
Latest round
$41 M
May 2022
First round on record
Apr 2021
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Vernal Biosciences, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2022$41 MNo. 2$10 to $50 million

Vernal Biosciences, Inc.: Raise no. 2, May 2022

Investors in this round

10 investors had bought by the notice of Jun 16, 2023: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$41 M of $41 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christian Cobaugh · Executive Officer, Director
  • Daniella Kranjac · Director
  • David Anderson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Christian Cobaugh, President. Newest notice filed Jun 16, 2023 (1 amendment). Read the notice at the SEC.

equitySEC
Apr 2021$2 MNo. 1Under $2 million

Vernal Biosciences, Inc.: Raise no. 1, Apr 2021

Investors in this round

9 investors had bought by the notice of May 24, 2021: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christian Cobaugh · Executive Officer, Director
  • Errik Anderson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Christian Cobaugh, President. Newest notice filed May 24, 2021. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Vernal Biosciences, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2023).

    SEC Form D · Jun 2023

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jun 2023

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Vernal Biosciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Vernal Biosciences, Inc.
NameRoleNamed in
Christian CobaughExecutive officerJun 2023
Christian CobaughDirectorJun 2023
Daniella KranjacDirectorJun 2023
David AndersonDirectorJun 2023
Errik AndersonDirectorMay 2022
Gustavo MahlerDirectorMay 2022